These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 18092271

  • 1. Urinary markers of altered collagen metabolism in fibromyalgia patients.
    Ribel-Madsen S, Christgau S, Gronemann ST, Bartels EM, Danneskiold-Samsøe B, Bliddal H.
    Scand J Rheumatol; 2007; 36(6):470-7. PubMed ID: 18092271
    [Abstract] [Full Text] [Related]

  • 2. A comparison of methods for measuring serum and urinary markers of bone metabolism in cats.
    DeLaurier A, Jackson B, Pfeiffer D, Ingham K, Horton MA, Price JS.
    Res Vet Sci; 2004 Aug; 77(1):29-39. PubMed ID: 15120950
    [Abstract] [Full Text] [Related]

  • 3. Urinary bone resorption markers (deoxypyridinoline and C-terminal telopeptide of type I collagen) in healthy persons, postmenopausal osteoporosis and patients with type I diabetes.
    Fassbender WJ, Gödde M, Brandenburg VM, Usadel KH, Stumpf UC.
    Adv Med Sci; 2009 Aug; 54(1):1-6. PubMed ID: 19482729
    [Abstract] [Full Text] [Related]

  • 4. Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis.
    Charni N, Juillet F, Garnero P.
    Arthritis Rheum; 2005 Apr; 52(4):1081-90. PubMed ID: 15818703
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Correlation of serum collagen I carboxyterminal telopeptide concentrations with cutaneous and pulmonary involvement in systemic sclerosis.
    Allanore Y, Borderie D, Lemaréchal H, Cherruau B, Ekindjian OG, Kahan A.
    J Rheumatol; 2003 Jan; 30(1):68-73. PubMed ID: 12508392
    [Abstract] [Full Text] [Related]

  • 8. Urinary markers of type I collagen degradation in the dog.
    Allen MJ, Allen LC, Hoffmann WE, Richardson DC, Breur GJ.
    Res Vet Sci; 2000 Oct; 69(2):123-7. PubMed ID: 11020362
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of surgical menopause and Paget's disease of bone on the isomerization of type I collagen carboxyterminal telopeptide: evolution after antiresorptive therapy.
    Peris P, Alvarez L, Monegal A, Guañabens N, Durán M, Echevarría M, Ros I, Ballesta AM, Muñoz-Gómez J.
    J Bone Miner Metab; 2002 Oct; 20(2):116-20. PubMed ID: 11862534
    [Abstract] [Full Text] [Related]

  • 11. Prognostic value of urinary pyridinium crosslinks and their derivatives in multiple myeloma.
    Samani KK, Brazier M, Mathiot C, Kamel S, Jamart J, Jaubert J, Blanc M, Azaïs I, Facon T, Leleu X.
    Ann Hematol; 2005 Jan; 84(1):19-24. PubMed ID: 15338198
    [Abstract] [Full Text] [Related]

  • 12. Relationships between the fibromyalgia impact questionnaire, tender point count, and muscle strength in female patients with fibromyalgia: a cohort study.
    Henriksen M, Lund H, Christensen R, Jespersen A, Dreyer L, Bennett RM, Danneskiold-Samsøe B, Bliddal H.
    Arthritis Rheum; 2009 Jun 15; 61(6):732-9. PubMed ID: 19479709
    [Abstract] [Full Text] [Related]

  • 13. Effects of age, menopause and osteoporosis on free, peptide-bound and total pyridinium crosslink excretion.
    Del Campo MT, González-Casaus ML, Aguado P, Bernad M, Carrera F, Martínez ME.
    Osteoporos Int; 1999 Jun 15; 9(5):449-54. PubMed ID: 10550465
    [Abstract] [Full Text] [Related]

  • 14. Diurnal variation in concentrations of various markers of bone metabolism in dogs.
    Liesegang A, Reutter R, Sassi ML, Risteli J, Kraenzlin M, Riond JL, Wanner M.
    Am J Vet Res; 1999 Aug 15; 60(8):949-53. PubMed ID: 10451203
    [Abstract] [Full Text] [Related]

  • 15. A cross-sectional study of bone turnover markers in healthy premenopausal women.
    de Papp AE, Bone HG, Caulfield MP, Kagan R, Buinewicz A, Chen E, Rosenberg E, Reitz RE.
    Bone; 2007 May 15; 40(5):1222-30. PubMed ID: 17331821
    [Abstract] [Full Text] [Related]

  • 16. Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage.
    Garnero P, Piperno M, Gineyts E, Christgau S, Delmas PD, Vignon E.
    Ann Rheum Dis; 2001 Jun 15; 60(6):619-26. PubMed ID: 11350852
    [Abstract] [Full Text] [Related]

  • 17. Urinary collagen type II C-telopeptide fragments are sensitive markers of matrix metalloproteinase-dependent cartilage degradation in rat adjuvant-induced arthritis.
    De Ceuninck F, Sabatini M, Renoux V, de Nanteuil G, Pastoureau P.
    J Rheumatol; 2003 Jul 15; 30(7):1561-4. PubMed ID: 12858459
    [Abstract] [Full Text] [Related]

  • 18. The combination of the biomarkers urinary C-terminal telopeptide of type II collagen, serum cartilage oligomeric matrix protein, and serum chondroitin sulfate 846 reflects cartilage damage in hemophilic arthropathy.
    Jansen NW, Roosendaal G, Lundin B, Heijnen L, Mauser-Bunschoten E, Bijlsma JW, Theobald M, Lafeber FP.
    Arthritis Rheum; 2009 Jan 15; 60(1):290-8. PubMed ID: 19116938
    [Abstract] [Full Text] [Related]

  • 19. Cartilage destruction in collagen induced arthritis assessed with a new biochemical marker for collagen type II C-telopeptide fragments.
    Ishikawa T, Nishigaki F, Christgau S, Noto T, Mo J, From N, Minoura K, Hirayama Y, Ohkubo Y, Mutoh S.
    J Rheumatol; 2004 Jun 15; 31(6):1174-9. PubMed ID: 15170932
    [Abstract] [Full Text] [Related]

  • 20. Hematic levels of type I collagen C-telopeptide in erosive versus nonerosive osteoarthritis of the hands.
    Rovetta G, Monteforte P, Grignolo MC, Brignone A, Buffrini L.
    Int J Tissue React; 2003 Jun 15; 25(1):25-8. PubMed ID: 12854884
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.